Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

A quick and cheap buyout benefits few.

Not sure why Thompson would choose to sell for 50 cents/share. He can probably reap greater rewards by holding out a year or more, at least.

Although my estimation will contradict enthusiasts, I believe we may reach a buck per share by the end of 2020, though this is a difficult call given all of the self-inflicted wounds the company has suffered from of late.

Once production has been established and we are on a steady footing, KBLB ought to be able to attract investment capital and grow in an organic fashion. We are a long way from a buyout of $6/share or higher, but I believe Thompson is planning to stay the course and aim high, not aim for 50 cents.